<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Aspirin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Aspirin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Cardiac / Vascular</div>
      <h1>Aspirin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Aspirin 325mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Suspected acute coronary syndrome / suspected MI</strong> (if no allergy/intolerance and no active major bleeding)</p>
        <ul>
          <li>Chew and swallow 160–325 mg as early as possible (use what you have available; you stock 325 mg tablets)</li>
        </ul>
        <p><strong>Pain/fever</strong> (less commonly needed if acetaminophen/NSAIDs preferred)</p>
        <ul>
          <li>325–650 mg PO every 4–6 hours as needed (max daily dose depends on indication and patient risk; use local guidance)</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Suspected acute myocardial infarction / unstable angina (antiplatelet effect)</li>
          <li>Secondary prevention in known vascular disease (provider-directed)</li>
          <li>Analgesic/antipyretic/anti-inflammatory uses (less common onboard vs other agents)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>ASA hypersensitivity, ASA-exacerbated respiratory disease</li>
          <li>Active significant bleeding or high bleeding risk; known bleeding disorder</li>
          <li>Severe uncontrolled peptic ulcer disease / recent GI bleed (risk–benefit)</li>
          <li>Caution with concurrent anticoagulants/antiplatelets and heavy alcohol use</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>For suspected MI: chew (do not just swallow whole) for faster effect</li>
          <li>Avoid "double-dosing" if patient already took ASA—confirm history if possible</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Watch for bleeding (GI symptoms, bruising) and allergic reaction/bronchospasm in sensitive patients</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Dyspepsia, nausea</li>
          <li>GI bleeding/ulceration (dose/risk dependent)</li>
          <li>Bronchospasm/hypersensitivity reactions (susceptible patients)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>In chest pain pathways: prioritize early ASA when indicated; document dose/time clearly</li>
          <li>If med history is unclear, use quick screening: allergy/intolerance + active bleeding history</li>
          <li>Plan for limited diagnostics: treat high-risk presentations conservatively and escalate/evac when indicated</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <p><strong>Video:</strong></p>
        <ul>
          <li><a href="https://www.youtube.com/watch?v=2d9c5bqv5mA">Chewable aspirin / heart attack public education</a></li>
        </ul>
        <p><strong>Documentation:</strong></p>
        <ul>
          <li><a href="https://pdf.hres.ca/dpd_pm/00061346.PDF">Health Canada product monograph (PDF)</a></li>
          <li><a href="https://www.heartandstroke.ca/heart-disease/conditions/heart-attack">Heart and Stroke Foundation – Heart Attack guidance</a></li>
          <li><a href="https://handbook.bcehs.ca/drug-monographs/acetylsalicylic-acid/">BC EHS Drug Monograph – Acetylsalicylic Acid</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
